apnea diagnosi focu
report result may aest forecast revenu growth
cc report ebit non-gaap npat vs pcp
limit impact expect expect pandem
minor impact result signific disrupt last two
week quarter follow strong trend januari februari forecast us
mask growth driven consist strong re-suppli growth aid brightre
continu ramp-up rmd new mask forecast us devic growth
ventil demand offset weaker sleep sale final two week march
strong ventil growth estim ventil make devic
sale commit increas ventil manufactur capac
due pandem take time sourc part manufactur
forecast increas ventil sale account group sale
growth estim ventil growth ventil
need current see risk over-suppli medium term
eye commentari around sleep diagnosi sleep lab close
part govern mandat lockdown expect sharp declin new patient
cpap set-up estim cpap devic sale new patient set-up
countri us home sleep test may still occur dont expect
off-set declin sleep lab diagnos forecast us devic sale
despit strong ventil growth estim
lower impact mask growth sale autom re-suppli
forecast us mask growth
retain neutral rate increas target price due
ep estim upgrad sign social distanc
restrict start eas quicker expect believ downsid risk
consensu estim stock trade price-to-earnings neutral rate
appropri view
valuat metric
chang previou ep
total return forecast perspect
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
 asx close
spot exchang rate
price
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
sleep diagnos focu result
figur detail revenu growth assumpt ahead rmd result believ
market particularli focus level sleep diagnosi impact
pandem subsequ stay-at-hom order new patient set-up
figur cs revenu growth assumpt
detail around assumpt includ
sleep devic growth estim ventil made devic sale histor
remain sleep estim sleep devic revenu new
patient set-up mani countri enter lock-down final two week march
assum littl sleep diagnos occur patient start cpap treatment
time us home-test may still occur lower rate vs previous
ventil growth end march state plan increas manufactur
capac ventil yet view still take time sourc
part manufactur product
mask assum mask revenu new set-up remain
re-suppli assum limit disrupt rmd mask growth
final week march like impact littl new set-up given re-suppli
autom dont anticip impact growth much
gross margin assum margin expans due posit mix shift
toward mask ventil vs sleep devic
sg forecast sg cost growth vs pcp
forecast group revenu growth repres revenu
pcp manag guidanc sale given sharp fall-off activ
last two week march unlik abl reduc cost base quickli
 forecast cost growth versu pcp
repres revenu consist manag guidanc
net interest cost forecast net interest cost line
oei loss verili forecast equiti loss result verili joint
ventur commenc line manag guidanc
incom oper
net interest
net profit tax
ahead result upgrad ep estim
assum economi eas lock-down restrict earlier previou estim
particular rais assumpt mask growth assum continu re-suppli
make chang estim weve also adjust estim latest fx
move current trade forward consensu earn ahead two
year averag repres premium rel industri ex-
financi given risk see level sleep diagnosi retain neutral rate
figur pe trade averag
figur premium market
pe rel industri ex-financi
rel xji ex fin charl martineau pm univers toronto april
figur sharp declin us devic growth
figur higher gross margin due mix shift
gross profit us mn gross margin
figur row devic growth
expens sale
figur forecast chang dividend
pcp us devicesu pcp row devicesrow margin gross profitgross profit roll gp margin month sale salescogssg ar debt/ebitdanet debtnet debtnet charl martineau pm univers toronto april
new total return forecast perspect chart help visual credit suiss consensu view compani return
within context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock
volatil stock volatil shade area show one standard deviat rang base past month volatil
statist term make number brave assumpt probabl share price end insid rang
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around
mean repres rang estim lowest highest estim aid visualis number import factor
rang analyst estim credit suiss estim stock sit rel consensu share price rel
consensu mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang
use consensu target price consensu dividend forecast month forward
compani mention price
gretel janu certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
